These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34549879)

  • 41. Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells.
    Batool S; Argyropoulos KV; Azad R; Okeoma P; Zumrut H; Bhandari S; Dekhang R; Mallikaratchy PR
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):232-240. PubMed ID: 30342154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
    Zhang WY; Chen HL; Chen QC
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HAPIscreen, a method for high-throughput aptamer identification.
    Dausse E; Taouji S; Evadé L; Di Primo C; Chevet E; Toulmé JJ
    J Nanobiotechnology; 2011 Jun; 9():25. PubMed ID: 21639912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
    Xiao X; Li H; Zhao L; Zhang Y; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of DNA aptamers using micro free flow electrophoresis.
    Jing M; Bowser MT
    Lab Chip; 2011 Nov; 11(21):3703-9. PubMed ID: 21947169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin.
    Tok JB; Fischer NO
    Chem Commun (Camb); 2008 Apr; (16):1883-5. PubMed ID: 18401506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gold nanoparticle-streptavidin conjugates for rapid and efficient screening of aptamer function in lateral flow sensors using novel CD4-binding aptamers identified through Crossover-SELEX.
    Fellows T; Ho L; Flanagan S; Fogel R; Ojo D; Limson J
    Analyst; 2020 Aug; 145(15):5180-5193. PubMed ID: 32567629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplex Aptamer Discovery through Apta-Seq and Its Application to ATP Aptamers Derived from Human-Genomic SELEX.
    Abdelsayed MM; Ho BT; Vu MMK; Polanco J; Spitale RC; Lupták A
    ACS Chem Biol; 2017 Aug; 12(8):2149-2156. PubMed ID: 28661647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Flow Cytometry and ELASA for Screening of Proper Candidate Aptamer in Cell-SELEX Pool.
    Nabavinia MS; Charbgoo F; Alibolandi M; Mosaffa F; Gholoobi A; Ramezani M; Abnous K
    Appl Biochem Biotechnol; 2018 Feb; 184(2):444-452. PubMed ID: 28721653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges and Opportunities in the Development of Aptamers for TNFα.
    Nübel C; Appel B; Hospach I; Mai M; Krasteva N; Nelles G; Petruschka L; Müller S
    Appl Biochem Biotechnol; 2016 Jun; 179(3):398-414. PubMed ID: 26922730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX.
    Wang G; Liu J; Chen K; Xu Y; Liu B; Liao J; Zhu L; Hu X; Li J; Pu Y; Zhong W; Fu T; Liu H; Tan W
    Sci Rep; 2017 Aug; 7(1):7179. PubMed ID: 28775305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selection of aptamers for a non-DNA binding protein in the context of cell lysate.
    Kanoatov M; Javaherian S; Krylov SN
    Anal Chim Acta; 2010 Nov; 681(1-2):92-7. PubMed ID: 21035608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2'-O,4'-C-methylene-bridged/locked nucleic acid primer.
    Kasahara Y; Irisawa Y; Fujita H; Yahara A; Ozaki H; Obika S; Kuwahara M
    Anal Chem; 2013 May; 85(10):4961-7. PubMed ID: 23662585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Function of ssDNA aptamer and aptamer pool against Mycobacterium tuberculosis in a mouse model.
    Chen F; Zhou J; Huang YH; Huang FY; Liu Q; Fang Z; Yang S; Xiong M; Lin YY; Tan GH
    Mol Med Rep; 2013 Feb; 7(2):669-73. PubMed ID: 23242377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the Influences of Random-Region Length on Aptamer Selection Efficiency Based on Capillary Electrophoresis-SELEX and High-Throughput Sequencing.
    Zhu C; Li L; Yang G; Qu F
    Anal Chem; 2021 Dec; 93(51):17030-17035. PubMed ID: 34908408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.